• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种新型肿瘤抑制基因与甲状腺乳头状癌的进展相关。

A novel tumor suppressor gene is correlated with progression in papillary thyroid carcinoma.

作者信息

Zheng Zhou-Ci, Wang Qing-Xuan, Zhang Wei, Zhang Xiao-Hua, Huang Du-Ping

机构信息

Department of Thyroid and Breast Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People's Republic of China.

出版信息

Onco Targets Ther. 2018 Jan 11;11:307-311. doi: 10.2147/OTT.S154158. eCollection 2018.

DOI:10.2147/OTT.S154158
PMID:29391807
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5769572/
Abstract

BACKGROUND

In contrast to the excellent prognosis for papillary thyroid carcinoma (PTC), the high incidence of lymph node metastasis (LNM) markedly increases the risk of recurrence and secondary surgery. Thus, novel biomarkers must be urgently identified to assess LNM for patients with PTC. NCOA5 is deeply involved in the progression of human cancer; however, its role in thyroid cancer remains unknown.

PATIENTS AND METHODS

Quantitative real-time polymerase chain reaction was conducted to investigate the expression of NCOA5 in PTC. RNA-seq data from The Cancer Genome Atlas (TCGA) database were downloaded to further understand the role of NCOA5 in PTC and its relationship with LNM.

RESULTS

NCOA5 was significantly downregulated in PTC tissues when compared with that in adjacent noncancerous thyroid tissues both in our local cohort and TCGA database. Reduced expression of NCOA5 was significantly associated with aggressive clinicopathological features, including histological type, tumor stage, BRAF-V600E mutation, LNM, extrathyroid extension, and clinical stage. Moreover, logistic analysis indicated that reduced expression of NCOA5, age, histological type, and clinical stage are independent high-risk factors for LNM in PTC.

CONCLUSION

Our study provides new insights and evidence that NOCA5 was significantly correlated with the progression of PTC and was particularly involved in LNM.

摘要

背景

与甲状腺乳头状癌(PTC)良好的预后相反,淋巴结转移(LNM)的高发生率显著增加了复发和二次手术的风险。因此,迫切需要鉴定新的生物标志物来评估PTC患者的LNM情况。NCOA5深度参与人类癌症的进展;然而,其在甲状腺癌中的作用尚不清楚。

患者与方法

采用定量实时聚合酶链反应研究NCOA5在PTC中的表达。从癌症基因组图谱(TCGA)数据库下载RNA测序数据,以进一步了解NCOA5在PTC中的作用及其与LNM的关系。

结果

在我们的本地队列和TCGA数据库中,与相邻的非癌甲状腺组织相比,PTC组织中NCOA5显著下调。NCOA5表达降低与侵袭性临床病理特征显著相关,包括组织学类型、肿瘤分期、BRAF-V600E突变、LNM、甲状腺外侵犯和临床分期。此外,逻辑分析表明,NCOA5表达降低、年龄、组织学类型和临床分期是PTC患者LNM的独立高危因素。

结论

我们的研究提供了新的见解和证据,表明NOCA5与PTC的进展显著相关,尤其参与LNM过程。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6921/5769572/2d32ba99f3f1/ott-11-307Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6921/5769572/6b5964cc8b2d/ott-11-307Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6921/5769572/2d32ba99f3f1/ott-11-307Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6921/5769572/6b5964cc8b2d/ott-11-307Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6921/5769572/2d32ba99f3f1/ott-11-307Fig2.jpg

相似文献

1
A novel tumor suppressor gene is correlated with progression in papillary thyroid carcinoma.一种新型肿瘤抑制基因与甲状腺乳头状癌的进展相关。
Onco Targets Ther. 2018 Jan 11;11:307-311. doi: 10.2147/OTT.S154158. eCollection 2018.
2
Nuclear Receptor Coactivator 5 is Correlated with Progression in Breast Carcinoma.核受体共激活因子 5 与乳腺癌的进展相关。
Anticancer Agents Med Chem. 2021;21(18):2520-2524. doi: 10.2174/1871520621666210126093630.
3
New global analysis of the microRNA transcriptome of primary tumors and lymph node metastases of papillary thyroid cancer.甲状腺乳头状癌原发肿瘤和淋巴结转移灶的微小RNA转录组的新全球分析。
BMC Genomics. 2015 Oct 21;16:828. doi: 10.1186/s12864-015-2082-3.
4
Underexpression of INPPL1 is associated with aggressive clinicopathologic characteristics in papillary thyroid carcinoma.INPPL1的低表达与甲状腺乳头状癌的侵袭性临床病理特征相关。
Onco Targets Ther. 2018 Nov 1;11:7725-7731. doi: 10.2147/OTT.S185803. eCollection 2018.
5
BRAF mutation is not associated with central lymph node metastasis in all patients with papillary thyroid cancer: Different histological subtypes and preoperative lymph node status should be taken into account.BRAF突变与所有甲状腺乳头状癌患者的中央淋巴结转移无关:应考虑不同的组织学亚型和术前淋巴结状态。
Oncol Lett. 2017 Oct;14(4):4122-4134. doi: 10.3892/ol.2017.6694. Epub 2017 Aug 1.
6
Downregulation of CDH16 in Papillary Thyroid Cancer and Its Potential Molecular Mechanism Analysed by qRT-PCR, TCGA and in silico Analysis.通过qRT-PCR、TCGA和计算机分析对甲状腺乳头状癌中CDH16的下调及其潜在分子机制进行分析
Cancer Manag Res. 2019 Dec 23;11:10719-10729. doi: 10.2147/CMAR.S229631. eCollection 2019.
7
Integrated Characterization of MicroRNA and mRNA Transcriptome in Papillary Thyroid Carcinoma.甲状腺乳头状癌中MicroRNA和mRNA转录组的综合表征
Front Endocrinol (Lausanne). 2018 Apr 16;9:158. doi: 10.3389/fendo.2018.00158. eCollection 2018.
8
Pigment epithelium-derived factor has a role in the progression of papillary thyroid carcinoma by affecting the HIF1α-VEGF signaling pathway.色素上皮衍生因子通过影响缺氧诱导因子1α-血管内皮生长因子信号通路在甲状腺乳头状癌进展中发挥作用。
Oncol Lett. 2016 Dec;12(6):5217-5222. doi: 10.3892/ol.2016.5316. Epub 2016 Oct 25.
9
Low metallothionein 1M (MT1M) is associated with thyroid cancer cell lines progression.低水平的金属硫蛋白1M(MT1M)与甲状腺癌细胞系的进展相关。
Am J Transl Res. 2019 Mar 15;11(3):1760-1770. eCollection 2019.
10
DUSP4/MKP2 overexpression is associated with BRAF(V600E) mutation and aggressive behavior of papillary thyroid cancer.双特异性磷酸酶4/丝裂原活化蛋白激酶磷酸酶2(DUSP4/MKP2)过表达与BRAF(V600E)突变及甲状腺乳头状癌的侵袭性行为相关。
Onco Targets Ther. 2016 Apr 15;9:2255-63. doi: 10.2147/OTT.S103554. eCollection 2016.

引用本文的文献

1
Prmt1-mediated histone H4R3me2a methylation regulates the proliferation, migration and invasion of laryngeal cancer cells by affecting the expression level of NCOA5.Prmt1介导的组蛋白H4R3me2a甲基化通过影响NCOA5的表达水平来调节喉癌细胞的增殖、迁移和侵袭。
Front Oncol. 2024 Dec 17;14:1489164. doi: 10.3389/fonc.2024.1489164. eCollection 2024.
2
Expression and clinical significance of NCOA5 in epithelial ovarian cancer.NCOA5在上皮性卵巢癌中的表达及临床意义
Front Oncol. 2023 May 1;13:1117033. doi: 10.3389/fonc.2023.1117033. eCollection 2023.
3
Knockdown of NCOA5 suppresses viability, migration and epithelial-mesenchymal transition, and induces adhesion of breast cancer cells.

本文引用的文献

1
Clinical significance of NCOA5 gene rs2903908 polymorphism in Behçet's disease.NCOA5基因rs2903908多态性在白塞病中的临床意义
EXCLI J. 2017 May 4;16:609-617. doi: 10.17179/excli2017-189. eCollection 2017.
2
Predictive Factors of Lymph Node Metastasis in Follicular Variant of Papillary Thyroid Carcinoma.滤泡型甲状腺乳头状癌淋巴结转移的预测因素。
Ann Surg Oncol. 2017 Sep;24(9):2617-2623. doi: 10.1245/s10434-017-5912-5. Epub 2017 Jul 6.
3
A single non-synonymous NCOA5 variation in type 2 diabetic patients with hepatocellular carcinoma impairs the function of NCOA5 in cell cycle regulation.
敲低NCOA5可抑制乳腺癌细胞的活力、迁移和上皮-间质转化,并诱导其黏附。
Oncol Lett. 2021 Oct;22(4):694. doi: 10.3892/ol.2021.12955. Epub 2021 Aug 1.
在患有肝细胞癌的2型糖尿病患者中,单个非同义NCOA5变异会损害NCOA5在细胞周期调控中的功能。
Cancer Lett. 2017 Apr 10;391:152-161. doi: 10.1016/j.canlet.2017.01.028. Epub 2017 Jan 27.
4
Cancer Statistics, 2017.《2017 年癌症统计》
CA Cancer J Clin. 2017 Jan;67(1):7-30. doi: 10.3322/caac.21387. Epub 2017 Jan 5.
5
NCOA5 is correlated with progression and prognosis in luminal breast cancer.NCOA5与腔面型乳腺癌的进展和预后相关。
Biochem Biophys Res Commun. 2017 Jan 8;482(2):253-256. doi: 10.1016/j.bbrc.2016.11.051. Epub 2016 Nov 12.
6
Occult lymph node metastasis and risk of regional recurrence in papillary thyroid cancer after bilateral prophylactic central neck dissection: A multi-institutional study.双侧预防性中央区颈淋巴结清扫术后甲状腺乳头状癌的隐匿性淋巴结转移及区域复发风险:一项多机构研究
Surgery. 2017 Feb;161(2):465-471. doi: 10.1016/j.surg.2016.07.031. Epub 2016 Aug 26.
7
Risk factors for recurrence in patients with papillary thyroid carcinoma undergoing modified radical neck dissection.行改良根治性颈清扫术的甲状腺乳头癌患者复发的风险因素。
Br J Surg. 2016 Jul;103(8):1020-5. doi: 10.1002/bjs.10144. Epub 2016 Apr 28.
8
Cancer statistics in China, 2015.《中国癌症统计数据 2015》
CA Cancer J Clin. 2016 Mar-Apr;66(2):115-32. doi: 10.3322/caac.21338. Epub 2016 Jan 25.
9
Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis.伴淋巴结转移的甲状腺乳头状癌术后复发
J Surg Oncol. 2015 Aug;112(2):149-54. doi: 10.1002/jso.23967. Epub 2015 Jul 15.
10
An LXR-NCOA5 gene regulatory complex directs inflammatory crosstalk-dependent repression of macrophage cholesterol efflux.一种LXR-NCOA5基因调控复合物指导巨噬细胞胆固醇外流的炎症串扰依赖性抑制。
EMBO J. 2015 May 5;34(9):1244-58. doi: 10.15252/embj.201489819. Epub 2015 Mar 9.